These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6335044)
21. Histocompatibility typing by cytotoxic lymphocytes. The HLA-A2-28, B5-w35 serologically cross-reactive groups reviewed by cytotoxic lymphocytes. Kristensen T; Malissen B; Charmot D; Mawas C; Kissmeyer-Nielsen F Tissue Antigens; 1981 May; 17(5):464-72. PubMed ID: 7336413 [No Abstract] [Full Text] [Related]
22. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15. Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883 [TBL] [Abstract][Full Text] [Related]
23. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12. Schäfer K; Albert ED; Rodt H; Thierfelder S Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938 [TBL] [Abstract][Full Text] [Related]
24. Reactivity of anti-HLA sera against mouse lymphocytes. Colombani J; Colombani M; Degos L; David CS; Shreffler DC Tissue Antigens; 1977 Feb; 9(2):111-20. PubMed ID: 65803 [TBL] [Abstract][Full Text] [Related]
25. Cytotoxic antibodies in cancer patients: possibilities of correlation with HLA antigens. Laurentaci G; Favoino B Boll Ist Sieroter Milan; 1981; 60(1):52-6. PubMed ID: 6973995 [TBL] [Abstract][Full Text] [Related]
26. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041 [TBL] [Abstract][Full Text] [Related]
27. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation. Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071 [TBL] [Abstract][Full Text] [Related]
28. The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Arce-Gomez B; Jones EA; Barnstable CJ; Solomon E; Bodmer WF Tissue Antigens; 1978 Feb; 11(2):96-112. PubMed ID: 77067 [TBL] [Abstract][Full Text] [Related]
29. [Attempt at blocking HLA-A, B, C antigens on lymphocytes with anti-beta 2-microglobulin SwAHu/B2m USOL. Negative result]. Májský A Cas Lek Cesk; 1983 Jan; 122(2):40-3. PubMed ID: 6186376 [No Abstract] [Full Text] [Related]
30. Reactivity of anti-HLA sera against mouse lymphocytes [proceedings]. Colombani J; Colombani M; Degos L; David CS; Shreffler DC Folia Biol (Praha); 1976; 22(6):374-5. PubMed ID: 1001555 [No Abstract] [Full Text] [Related]
31. Chicken Mhc alloantiserum cross-reactivity analysis by hemagglutination and flow cytometry. Fulton JE; Young EE; Bacon LD Immunogenetics; 1996; 43(5):277-88. PubMed ID: 9110931 [TBL] [Abstract][Full Text] [Related]
32. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens. Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665 [TBL] [Abstract][Full Text] [Related]
33. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies. Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889 [TBL] [Abstract][Full Text] [Related]
34. The human cytotoxic T cell response to influenza A vaccination. McMichael AJ; Gotch F; Cullen P; Askonas B; Webster RG Clin Exp Immunol; 1981 Feb; 43(2):276-84. PubMed ID: 6974066 [TBL] [Abstract][Full Text] [Related]
35. High panel reactive antibody against cross-reactive group antigens as a contraindication to renal allotransplantation. Dilioglou S; Cruse JM; Lewis RE Exp Mol Pathol; 2001 Aug; 71(1):73-8. PubMed ID: 11502099 [TBL] [Abstract][Full Text] [Related]
36. Tissue antigens and cytotoxic antibodies in polycythaemia rubra vera. Nagy G; Stenszky V; Murvay K Haematologia (Budap); 1975; 9(3-4):279-82. PubMed ID: 1230410 [TBL] [Abstract][Full Text] [Related]
37. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies. Bućin D; Johansson S; Lindberg LO Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800 [TBL] [Abstract][Full Text] [Related]
38. A feasibility study of human leukocyte antigen (HLA) typing for dried bloodstains. Nelson MS; Turner LL; Reisner EG J Forensic Sci; 1983 Jul; 28(3):608-14. PubMed ID: 6619780 [TBL] [Abstract][Full Text] [Related]
39. [Study of an antiserum suggesting the existence of an HL-A locus different from those described up to now]. Cecchi V; Luciani G; Fagiolo U Riv Emoter Immunoematol; 1975; 22(5-6):147-57. PubMed ID: 1226482 [No Abstract] [Full Text] [Related]
40. HLA variants of human lymphoblastoid cell lines as targets for cytotoxic T cells: analysis of CTL reactivity against 2 HLA-DR variants. Newman W; Pious D; Gladstone P J Immunol; 1980 Dec; 125(6):2515-20. PubMed ID: 6968788 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]